Related Practice Life Sciences & Pharma Orphan drugs are expected to play an increasingly prominent role in the biopharmaceutical industry. The worldwide orphan market grew at ~8 percent per year over the past five years (from $79B to $114B). 08052019090827
Executive Insights Life Sciences & Pharma Transitioning to EU-Wide Health Technology Assessments: Implications for Pharma April 14, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024